Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24969513 | 0.99 | OPRD1 (0.98) | OPRD1OPRK1 | |
| Hydrochloric Acid SCHEMBL30206754 | 0.99 | OPRD1 (0.98) | OPRD1OPRK1 | |
| Hydrochloric Acid SCHEMBL30206752 | 0.98 | OPRD1 (0.96) | OPRD1OPRK1 | |
| SCHEMBL24969507 | 0.98 | OPRK1 (1.00) | OPRD1OPRK1 | |
| Hydrochloric Acid SCHEMBL30206782 | 0.97 | OPRK1 (0.98) | OPRD1OPRK1 | |
| SCHEMBL24969502 | 0.96 | OPRD1 (1.00) | OPRD1OPRK1 | |
| Hydrochloric Acid SCHEMBL30206657 | 0.95 | OPRD1 (0.98) | OPRD1OPRK1 | |
| SCHEMBL28555688 | 0.89 | OPRD1 (0.82) | OPRD1OPRK1 | |
| SCHEMBL28561605 | 0.89 | OPRD1 (0.82) | OPRD1OPRK1 | |
| SCHEMBL24970012 | 0.84 | OPRK1 (0.84) | OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112759587-B | 3- (dimethylamino methyl) piperidine-4-alcohol derivative and preparation method and pharmaceutical application thereof | 复旦大学 | 2022-12-30 | — | — | CN | claimed |
| US-20230027752-A1 | OPIOID RECEPTOR AGONIST, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF | FUDAN UNIVERSITY (CN) | 2023-01-26 | — | — | US | disclosed |
| CN-112759587-B | 3- (dimethylamino methyl) piperidine-4-alcohol derivative and preparation method and pharmaceutical application thereof | 复旦大学 | 2022-12-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230027752-A1 | OPIOID RECEPTOR AGONIST, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF | OPRM1, OPRD1, OPRL1 | OPRD1 2/4885OPRK1 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.